NCT05626530 Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients Status RECRUITING Phase PHASE4
NCT05585463 Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021) Status COMPLETED Phase N/A
NCT05537896 Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia Status RECRUITING Phase PHASE2
NCT05283616 Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer Status COMPLETED Phase PHASE3
NCT05221593 Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients Status COMPLETED Phase PHASE3
NCT04873765 Biosimilarity Study of Subcutaneous Pegfilgrastim in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04710212 Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies Status COMPLETED Phase N/A
NCT04562922 LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy Status COMPLETED Phase PHASE2
NCT04187898 Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer Status COMPLETED Phase PHASE1
NCT04174599 Study to Compare the Efficacy and Safety of F-627 and GRAN® Status COMPLETED Phase PHASE3
NCT04154488 A Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders Status COMPLETED Phase PHASE1/PHASE2
NCT04009941 Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer Status COMPLETED Phase PHASE4
NCT03798665 A Real World Study Evaluating the Clinical Application of PEG-rhG-CSF During Chemotherapy in Patients With Solid Tumors Status UNKNOWN Phase N/A
NCT03530072 Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients Status COMPLETED Phase N/A
NCT03252431 Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy Status COMPLETED Phase PHASE3